ANNORA PHARMA FDA Approval ANDA 215375

ANDA 215375

ANNORA PHARMA

FDA Drug Application

Application #215375

Application Sponsors

ANDA 215375ANNORA PHARMA

Marketing Status

Prescription001

Application Products

001FOR SOLUTION;ORAL50MG0DICLOFENAC POTASSIUMDICLOFENAC POTASSIUM

FDA Submissions

UNKNOWN; ORIG1AP2022-03-04STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

ANNORA PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215375
            [companyName] => ANNORA PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"DICLOFENAC POTASSIUM","activeIngredients":"DICLOFENAC POTASSIUM","strength":"50MG","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/04\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-03-04
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.